Lineage Cell Therapeutics, Inc. (LCTX)

1.835 +0.06 (+3.67%) USD  |  NYAM  |  Feb 24, 14:01
More

Lineage Cell Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for LCTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Nephros, Inc. Upgrade
ProKidney Corp. --
ACADIA Pharmaceuticals, Inc. Upgrade
Agenus, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade